JSN Healthcare

8mg SEMANIZE (Semaglutide) injection is used primarily for managing type 2 diabetes to control blood sugar and for long-term weight management, helping with weight loss in adults with obesity or overweight who have weight-related conditions, by mimicking the GLP-1 hormone to increase insulin, reduce appetite, and slow stomach emptying. It's also prescribed to lower the risk of major cardiovascular events (heart attack, stroke, death) in type 2 diabetes patients with heart disease, and in adults with obesity/overweight and heart disease. This higher dose, often used when lower doses aren't enough, also helps manage kidney disease and, recently approved, MASH (liver disease). 

Glycoheal 500mg Tablets (Metformin IP) are primarily used to manage Type 2 Diabetes by lowering blood sugar, improving insulin sensitivity, and reducing glucose production in the liver, also helping to prevent complications like kidney or eye damage; they are also used for Polycystic Ovary Syndrome (PCOS) to regulate cycles and improve fertility. Key actions include delaying sugar absorption, increasing insulin sensitivity, and reducing liver glucose, often taken with meals for better tolerance

Empacon 25 mg (Empagliflozin) tablet is an SGLT2 inhibitor primarily used to manage Type 2 diabetes mellitus in adults by lowering high blood sugar. It aids in reducing the risk of cardiovascular death in patients with diabetes and heart disease, helps manage heart failure, and slows the progression of chronic kidney disease

Semaglutide works by helping the pancreas release a fair amount of insulin when blood glucose levels are high. Insulin directs the muscle and fat cells to take in glucose, which is utilized for energy. Semaglutide also suppresses glucagon release (a hormone that raises blood glucose